Skip to main content
. 2024 Dec 9;26:e55161. doi: 10.2196/55161

Table 1.

Coefficients, CI, and P values for Model 0-3.

Coefficient Model 0a Model 1b Model 2c Model 3d

OR (95% CI) P values OR (95% CI) P values OR (95% CI) P values OR (95% CI) P values
Intercept 0.14 (0.12-0.17) <.001 3.49 (1.76-6.92) <.001 5.18 (2.41-11.13) <.001 359.87 (55.38-2338.31) <.001
Day of measurement e 0.97 (0.96-0.98) <.001 0.97 (0.96-0.98) <.001 0.97 (0.96-0.99) <.001
Self-rated health 0.44 (0.37-0.52) <.001 0.40 (0.32-0.49) <.001 0.80 (0.64-1.01) <.001
Initial occurrence of Symptoms (yes) 9.28 (6.06- 14.22) <.001 13.95 (6.20-31.37) <.001 5.97 (3.67-9.72) <.001
General and unspecified (present) 3.33 (1.92-5.56) <.001
Eye (present) 5.56 (2.08-12.29) <.001
Cardiovascular (present) 8.33 (2.70-25.00) <.001
Musculoskeletal (present) 5.26 (3.44-8.33) <.001
Skin (present) 4.76 (2.04-11.11) <.001

aσ2=3.29; τ00=0.18ID; Bayesian information criterion=1568.02; intraclass correlation coefficient=0.05; N=48 (2016 observations).

bσ2=3.29; τ00=0.26ID; Bayesian information criterion=1306.17; intraclass correlation coefficient=0.07; N=48 (2016 observations).

cσ2=3.29; τ00=0.40Intercept; τ11=0.03 (participant-rated health) and 3.26 (first-time appearance of symptoms); ρ01=–0.65 and –0.06; Bayesian information criterion=1328.20; intraclass correlation coefficient=0.13; N=48 (2016 observations).

dσ2=3.29; τ00=1.14Intercept; τ11=1.53 (general and unspecified); ρ01=–0.89ID; Bayesian information criterion=1134.82; intraclass correlation coefficient=0.13; N=48 (2016 observations).

eNot applicable.